GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer

Part of paid clinical trials in San Francisco, California.

Sponsor
Stanford University
Study ID
NCT05415007
Status
Recruiting
Apply to this trial

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
8 Years - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • GOLD Program — BEHAVIORAL
    Participant will receive a 2-hour interventional session
  • Treatment as usual (TAU) — BEHAVIORAL
    Participant will receive treatment-As-Usual which consist of information about diagnosis routinely-disseminated by personnel and providers.

Study Details

The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.

Key Dates

Start date
Sep 21, 2022
Status verified
Jul 2025
Primary completion
Dec 31, 2026
Completion
Jun 30, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: GOLD Psychosocial Program
    Participant will receive a 2-hour interventional session. Its content will consist of two modules: (1) psychoeducation and coping, providing information in content areas such as side effects of cancer treatments, fever protocols, role disruption and (2) stress, triggers, and self care, where caregivers will be briefed on symptoms of and reactions to traumatic stress in order to help parents accurately label thoughts and emotions related to their child's cancer diagnosis.
  • Active Comparator: Treatment-as-Usual (TAU)

Primary Outcome Measure

Number of caregivers who enroll in the GOLD program [ Time Frame: 1 month ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford Cancer InstituteSan FranciscoCalifornia94305
Victoria E. Cosgrove, PhD
[email protected]
650-995-6848
Sheri Spunt, MD (SUB_INVESTIGATOR)

Find similar trials in San Francisco, CA

By research site
Stanford Cancer Institute· San Francisco, CA

Related Studies